Position in KURA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$24,848,925
+$13,194,807 QoQ
Shares Held
2,265,171
+58.0% QoQ
Ownership
2.55%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 220 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KURA Over Time
Shares Held
Position Value (USD)
Derivatives in KURA
reported options exposure · as of Dec 31, 2020CallValue
$2,286,200
CallShares
70,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. KURA ranks #102 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in KURA
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,848,925 | 2,265,171 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $11,654,118 | 1,433,471 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $19,089,172 | 1,837,264 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $23,140,324 | 2,614,726 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,387,275 | 933,670 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,469,954 | 828,781 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $7,517,469 | 863,085 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $13,863,316 | 709,484 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $17,128,511 | 831,885 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $16,762,734 | 785,876 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $7,643,861 | 531,562 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $4,202,467 | 460,797 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $9,843,186 | 930,358 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $13,291,563 | 1,086,800 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $14,240,362 | 1,147,491 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $19,612,917 | 1,435,792 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $17,688,926 | 965,026 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $7,737,534 | 481,190 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,287,878 | 306,277 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $5,276,559 | 281,717 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $3,551,651 | 170,343 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $29,514,105 | 1,044,008 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $40,997,999 | 1,255,297 | Shares | Defined | 2021-02-12 | |
| 2020-12-31 | $2,286,200 | 70,000 | Call | Defined | 2021-02-12 | |
| 2020-09-30 | $18,515,629 | 604,296 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $10,296,905 | 631,712 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $959,587 | 96,441 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||